keyword
https://read.qxmd.com/read/37893472/neurological-outcome-and-respiratory-insufficiency-in-intramedullary-tumors-of-the-upper-cervical-spine
#21
JOURNAL ARTICLE
Kateryna Goloshchapova, Maria Goldberg, Bernhard Meyer, Maria Wostrack, Vicki M Butenschoen
Background and Objectives: Intramedullary spinal cord tumors (IMSCT) are rare entities. A location in the upper cervical spine as a highly eloquent region carries the risk of postoperative neurological deficits, such as tetraparesis or respiratory dysfunction. Evidence for respiratory dysfunction is scarce. This study aimed to describe these highly eloquent tumors' early and late postoperative clinical course. Materials and Methods: This is a single-center retrospective cohort study. We included 35 patients with IMSCT at levels of the craniocervical junction to C4 who underwent surgical treatment between 2008 and 2022...
September 30, 2023: Medicina
https://read.qxmd.com/read/37868410/naturopathic-treatment-of-grade-iii-oligodendroglioma-with-progression-to-grade-iv-isocitrate-dehydrogenase-idh-mutant-astrocytoma-and-the-development-of-spinal-gliomatosis
#22
Kristina F Terrani, Conner D Reynolds, Samuel N Rogers
Primary intracranial gliomas are a heterogeneous class of lesions that rarely metastasize. Even more infrequently, they may spread caudally into the spinal cord causing spinal gliomatosis. In this case, we discuss an 18-year-old male patient with a diagnosis of grade IV astrocytoma with spinal gliomatosis, specifically detailing the radiographic progression of the disease over 38 months. We also discuss the significance of the change in the WHO classification of central nervous system tumors, as this patient's survival duration is inconsistent with the low survival rates expected of glioblastoma, and rather more consistent with a grade IV astrocytoma...
September 2023: Curēus
https://read.qxmd.com/read/37865172/a-novel-strategy-to-increase-the-therapeutic-potency-of-gbm-chemotherapy-via-altering-parenchymal-cerebral-spinal-fluid-clearance-rate
#23
JOURNAL ARTICLE
Benjamin J Umlauf, Gabriel Frampton, Alexis Cooper, Hannah-Faith Greene
Patients with glioblastoma (GBM) face a poor prognosis with a median survival of less than two years. Escalating the dose of chemotherapy is often impossible due to patient comorbidities; thus, we focused on modulating brain clearance as a mechanism to enhance drug accumulation. Given the recently identified interconnectivity between brain parenchymal fluid and cerebral spinal fluid (CSF), we reasoned enhancing drug concentration in the CSF also increases drug concentration in the parenchyma where a GBM resides...
October 19, 2023: Journal of Controlled Release
https://read.qxmd.com/read/37791212/strike-out-a-case-report-of-glioblastoma-in-a-collegiate-softball-player
#24
Rock P Vomer, Dusty Narducci, Rayghan S Larick, Emma York, Kristin Terry
A 20-year-old female, right-hand-dominant Division I softball player, presented to her pre-participation exam endorsing numbness that started in her left thumb and had progressed to involve her entire hand and left medial elbow. She had no change in her physical health over the past year prior to presentation and denied injury illness or trauma to the left upper extremity or neck. She reported no change in her softball off-season training regimen or equipment. Exam exhibited decreased sensation in C6, C7, and C8 dermatomes and weakness in the C8 myotome...
August 2023: Curēus
https://read.qxmd.com/read/37715122/leptomeningeal-neuraxis-relapse-in-glioblastoma-is-an-uncommon-but-not-rare-event-associated-with-poor-outcome
#25
JOURNAL ARTICLE
Eric Wegener, Patrick Horsley, Helen Wheeler, Dasantha Jayamanne, Marina Kastelan, Linxin Guo, Chris Brown, Michael Back
BACKGROUND: Spinal neuraxis leptomeningeal metastasis (LM) relapse in glioblastoma is an uncommon event that is challenging to manage. This study aims to determine the incidence, associated factors, and outcome of LM relapse in patients with glioblastoma managed with radical intent. METHODS: Patients managed for glioblastoma using the EORTC-NCIC (Stupp) Protocol from 2007 to 2019 were entered into a prospective ethics-approved database. Follow-up included routine cranial MRI surveillance with further imaging as clinically indicated...
September 15, 2023: BMC Neurology
https://read.qxmd.com/read/37675821/unraveling-the-signaling-mechanism-behind-astrocytoma-and-possible-therapeutics-strategies-a-comprehensive-review
#26
REVIEW
Chowdhury Lutfun Nahar Metu, Sunita Kumari Sutihar, Md Sohel, Fatematuz Zohora, Akayed Hasan, Md Thandu Miah, Tanu Rani Kar, Md Arju Hossain, Md Habibur Rahman
BACKGROUND: A form of cancer called astrocytoma can develop in the brain or spinal cord and sometimes causes death. A detailed overview of the precise signaling cascade underlying astrocytoma formation has not yet been revealed, although various factors have been investigated. Therefore, our objective was to unravel and summarize our current understanding of molecular genetics and associated signaling pathways with some possible therapeutic strategies for astrocytoma. RECENT FINDINGS: In general, four different forms of astrocytoma have been identified in individuals, including circumscribed, diffuse, anaplastic, and multiforme glioblastoma, according to a recent literature review...
September 7, 2023: Cancer reports
https://read.qxmd.com/read/37593069/intradural-intramedullary-spinal-cord-glioblastoma-a-case-report
#27
Pritee Shrestha, Tara Eineichner, Brittany Wilson, Naomi S Lam
Primary spinal cord glioblastoma multiforme (GBM) remains uncommon and typically affects males and patients during their fifth decade of life. Our case demonstrates a 77-year-old woman who initially presented with right arm paresthesia and limited range of motion and was subsequently diagnosed with primary spinal cord GBM. Our case illustrates an atypical and nonspecific neurological presentation highlighting that spinal cord GBM can have a more indolent course, unlike what current literature suggests. It also emphasizes the importance of considering a multimodal approach when managing atypical neurological symptoms and considering an early intervention, including magnetic resonance imaging, to rule out occult neoplasm in an appropriate clinical setting, thus preventing delay in the diagnosis...
August 2023: Curēus
https://read.qxmd.com/read/37452954/malignant-spinal-tumors
#28
JOURNAL ARTICLE
Mohammad Hassan A Noureldine, Nir Shimony, George I Jallo
Malignant spinal tumors constitute around 22% of all primary spinal tumors. The most common location of metastases to the spinal region is the extradural compartment. The molecular and genetic characterization of these tumors was the basis for the updated WHO classification of CNS tumors in 2016, where many CNS tumors are now diagnosed according to their genetic profile rather than relying solely on the histopathological appearance. Magnetic resonance imaging (MRI) is the current gold standard for the initial evaluation and subsequent follow-up on intradural spinal cord tumors, and the imaging sequences must include T2-weighted images (WI), short time inversion recovery (STIR), and pre- and post-contrast T1-WI in the axial, sagittal, and coronal planes...
2023: Advances in Experimental Medicine and Biology
https://read.qxmd.com/read/37427669/3d-conformal-very-high-energy-electron-therapy-as-candidate-modality-for-flash-rt-a-treatment-planning-study-for-glioblastoma-and-lung-cancer
#29
JOURNAL ARTICLE
Till Tobias Böhlen, Jean-François Germond, Erik Traneus, Veronique Vallet, Laurent Desorgher, Esat Mahmut Ozsahin, François Bochud, Jean Bourhis, Raphaël Moeckli
BACKGROUND: Pre-clinical ultra-high dose rate (UHDR) electron irradiations on time scales of 100 ms have demonstrated a remarkable sparing of brain and lung tissues while retaining tumor efficacy when compared to conventional dose rate irradiations. While clinically-used gantries and intensity modulation techniques are too slow to match such time scales, novel very-high energy electron (VHEE, 50-250 MeV) radiotherapy (RT) devices using 3D-conformed broad VHEE beams are designed to deliver UHDR treatments that fulfill these timing requirements...
July 10, 2023: Medical Physics
https://read.qxmd.com/read/37336070/resveratrol-as-an-antitumor-agent-for-glioblastoma-multiforme-targeting-resistance-and-promoting-apoptotic-cell-deaths
#30
REVIEW
Sepideh Karkon-Shayan, Hasan Aliashrafzadeh, Hassan Dianat-Moghadam, Nima Rastegar-Pouyani, Mohammadreza Majidi, Mahdi Zarei, Sadegh Moradi-Vastegani, Yaser Bahramvand, Sepideh Babaniamansour, Emad Jafarzadeh
Glioblastoma multiforme (GBM) is one of the most aggressive brain and spinal cord tumors. Despite the significant development in application of antitumor drugs, no significant increases have been observed in the survival rates of patients with GBM, as GBM cells acquire resistance to conventional anticancer therapeutic agents. Multiple studies have revealed that PI3K/Akt, MAPK, Nanog, STAT 3, and Wnt signaling pathways are involved in GBM progression and invasion. Besides, biological processes such as anti-apoptosis, autophagy, angiogenesis, and stemness promote GBM malignancy...
June 17, 2023: Acta Histochemica
https://read.qxmd.com/read/37289266/artificial-intelligence-and-radiation-effects-on-brain-tissue-in-glioblastoma-patient-preliminary-data-using-a-quantitative-tool
#31
JOURNAL ARTICLE
Donatella Franco, Vincenza Granata, Roberta Fusco, Roberta Grassi, Valerio Nardone, Laura Lombardi, Salvatore Cappabianca, Renata Conforti, Francesco Briganti, Roberto Grassi, Ferdinando Caranci
PURPOSE: The quantification of radiotherapy (RT)-induced functional and morphological brain alterations is fundamental to guide therapeutic decisions in patients with brain tumors. The magnetic resonance imaging (MRI) allows to define structural RT-brain changes, but it is unable to evaluate early injuries and to objectively quantify the volume tissue loss. Artificial intelligence (AI) tools extract accurate measurements that permit an objective brain different region quantification. In this study, we assessed the consistency between an AI software (Quibim Precision® 2...
June 8, 2023: La Radiologia Medica
https://read.qxmd.com/read/37210528/recent-advances-in-the-detection-of-glioblastoma-from-imaging-based-methods-to-proteomics-and-biosensors-a-narrative-review
#32
REVIEW
Arianaz Hosseini, Hami Ashraf, Fatemeh Rahimi, Iraj Alipourfard, Vahid Alivirdiloo, Behnam Hashemi, Yalda Yazdani, Farhood Ghazi, Majid Eslami, Mahdieh Ameri Shah Reza, Mehdi Dadashpour
Glioblastoma (GBM) is an aggressive type of cancer that originates in the cells called astrocytes, which support the functioning of nerve cells. It can develop in either the brain or the spinal cord and is also known as glioblastoma multiform. GBM is a highly aggressive cancer that can occur in either the brain or spinal cord. The detection of GBM in biofluids offers potential advantages over current methods for diagnosing and treatment monitoring of glial tumors. Biofluid-based detection of GBM focuses on identifying tumor-specific biomarkers in blood and cerebrospinal fluid...
May 20, 2023: Cancer Cell International
https://read.qxmd.com/read/37099272/correction-to-natural-history-of-spinal-cord-metastasis-from-brain-glioblastomas
#33
Aymeric Amelot, Louis-Marie Terrier, Gabrielle Cognacq, Vincent Jecko, Benoit Marlier, Romuald Seizeur, Evelyne Emery, Luc Bauchet, Vincent Roualdes, Jimmy Voirin, Christophe Joubert, Emmanuel Mandonnet, Leslie Lemnos, Bertrand Mathon, Pierre-Jean Le Reste, Andres Coca, Antoine Petit, Valérie Rigau, Karima Mokhtari, Audrey Rousseau, Philippe Metellus, Dominique Figarella-Branger, Guillaume Gauchotte, Kaissar Farah, Johan Pallud, Ilyess Zemmoura
No abstract text is available yet for this article.
April 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/36991306/natural-history-of-spinal-cord-metastasis-from-brain-glioblastomas
#34
JOURNAL ARTICLE
Aymeric Amelot, Louis-Marie Terrier, Gabrielle Cognacq, Vincent Jecko, Benoit Marlier, Romuald Seizeur, Evelyne Emery, Luc Bauchet, Vincent Roualdes, Jimmy Voirin, Christophe Joubert, Emmanuel Mandonnet, Leslie Lemnos, Bertrand Mathon, Pierre-Jean Le Reste, Andres Coca, Antoine Petit, Valérie Rigau, Karima Mokhtari, Audrey Rousseau, Philippe Metellus, Dominique Figarella-Branger, Guillaume Gauchotte, Kaissar Farah, Johan Pallud, Ilyess Zemmoura
BACKGROUND AND OBJECTIVES: Spinal cord metastasis arising from an intracranial glioblastoma is a rare and late event during the natural course of the disease. These pathological entities remain poorly characterized. This study aimed to identify and investigate the timeline, clinical and imaging findings, and prognostic factors of spinal cord metastasis from a glioblastoma. METHODS: Consecutive histopathological cases of spinal cord metastasis from glioblastomas in adults entered in the French nationwide database between January 2004 and 2016 were screened...
March 29, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/36917314/brain-washing-and-neural-health-role-of-age-sleep-and-the-cerebrospinal-fluid-melatonin-rhythm
#35
REVIEW
Russel J Reiter, Ramaswamy Sharma, Maira Smaniotto Cucielo, Dun Xian Tan, Sergio Rosales-Corral, Giuseppe Gancitano, Luiz Gustavo de Almeida Chuffa
The brain lacks a classic lymphatic drainage system. How it is cleansed of damaged proteins, cellular debris, and molecular by-products has remained a mystery for decades. Recent discoveries have identified a hybrid system that includes cerebrospinal fluid (CSF)-filled perivascular spaces and classic lymph vessels in the dural covering of the brain and spinal cord that functionally cooperate to remove toxic and non-functional trash from the brain. These two components functioning together are referred to as the glymphatic system...
March 14, 2023: Cellular and Molecular Life Sciences: CMLS
https://read.qxmd.com/read/36861587/a-novel-case-of-primary-conus-medullaris-epithelioid-glioblastoma-with-gliosarcomatous-differentiation
#36
Kiran P Malhotra, Mohammad Kaif, Hardeep Singh Malhotra, Nuzhat Husain
Intramedullary location is seldom seen in spinal cord neoplasms. Ependymomas and astrocytomas comprise the vast majority of these intramedullary lesions. Primary spinal origin is rarely seen in gliosarcomas. No epithelioid glioblastomas have been reported in the spine. We describe the case of an 18-year-old male who presented with symptoms suggestive of a spinal mass lesion. Magnetic resonance imaging revealed a homogeneous intradural-intramedullary lesion involving the conus medullaris. Biopsy of the lesion showed a unique morphology comprising gliosarcoma and epithelioid glioblastoma differentiation, supported by relevant immunohistochemistry...
2023: Neurology India
https://read.qxmd.com/read/36804437/impact-of-extent-of-resection-and-adjuvant-therapy-in-diffuse-gliomas-of-the-spine
#37
JOURNAL ARTICLE
Eric J Chalif, Chase Foster, Kenneth Sack, Hayes Patrick, Khashayar Mozaffari, Michael Rosner
BACKGROUND CONTENT: Diffuse gliomas of the spine (DGS)-consisting of intradural intramedullary glioblastoma, astrocytoma, and oligodendroglioma-are exceedingly rare tumors that account for about 2% of primary spinal cord tumors. Much is unknown about their optimal treatment regimen due to a relative lack of clinical outcome data. PURPOSE: To provide an updated analysis on treatment and outcomes in DGS. STUDY DESIGN/SETTING: Observational cohort study using The National Cancer Database (NCDB), a multicenter prospectively collected oncology outcomes database...
February 17, 2023: Spine Journal: Official Journal of the North American Spine Society
https://read.qxmd.com/read/36780420/leucine-rich-repeats-containing-4-protein-lrrc4-in-memory-psychoneurosis-and-glioblastoma
#38
REVIEW
Kun Deng, Minghua Wu
Leucine-rich repeats containing 4 ( LRRC4 , also named netrin-G ligand 2 [NGL-2]) is a member of the NetrinGs ligands (NGLs) family. As a gene with relatively high and specific expression in brain, it is a member of the leucine-rich repeat superfamily and has been proven to be a suppressor gene for gliomas, thus being involved in gliomagenesis. LRRC4 is the core of microRNA-dependent multi-phase regulatory loops that inhibit the proliferation and invasion of glioblastoma (GB) cells, including LRRC4/NGL2-activator protein 2 (AP2)-microRNA (miR) 182-LRRC4 and LRRC4-miR185-DNA methyltransferase 1 (DNMT1)-LRRC4/specific protein 1 (SP1)-DNMT1-LRRC4...
January 5, 2023: Chinese Medical Journal
https://read.qxmd.com/read/36751054/genomic-profiling-and-prognostic-factors-of-h3-k27m-mutant-spinal-cord-diffuse-glioma
#39
JOURNAL ARTICLE
Rui-Chao Chai, Hao Yan, Song-Yuan An, Bo Pang, Hui-Yuan Chen, Quan-Hua Mu, Ke-Nan Zhang, Yao-Wu Zhang, Yu-Qing Liu, Xing Liu, Zheng Zhao, Tao Jiang, Yong-Zhi Wang, Wen-Qing Jia
H3 K27-altered diffuse midline glioma is a highly lethal pediatric-type tumor without efficacious treatments. Recent findings have highlighted the heterogeneity among diffuse midline gliomas with different locations and ages. Compared to tumors located in the brain stem and thalamus, the molecular and clinicopathological features of H3 K27-altered spinal cord glioma are still largely elusive, thus hindering the accurate management of patients. Here we aimed to characterize the clinicopathological and molecular features of H3 K27M-mutant spinal cord glioma in 77 consecutive cases...
February 7, 2023: Brain Pathology
https://read.qxmd.com/read/36690453/natural-course-and-prognosis-of-primary-spinal-glioblastoma-a-nationwide-study
#40
JOURNAL ARTICLE
Aymeric Amelot, Louis-Marie Terrier, Bertrand Mathon, Christophe Joubert, Thiebaud Picart, Vincent Jecko, Luc Bauchet, Florian Benard, Xavier Castel, Louis Chenin, Ann-Rose Cook, Evelyne Emery, Dominique Figarella-Branger, Guillaume Gauchotte, Thomas Graillon, Anne Jouvet, Michel Kalamarides, Steven Knafo, Arnaud Lazard, Vincent Lubrano, Karima Mokhtari, Valérie Rigau, Vincent Roualdes, Audrey Rousseau, Romuald Seizeur, Emmanuelle Uro-Coste, Jimmy Voirin, Philippe Metellus, Johan Pallud, Ilyess Zemmoura
BACKGROUND AND OBJECTIVES: Primary spinal glioblastoma is extremely rare. The dramatic neurological deterioration and unresectability of primary spinal glioblastoma makes it a particularly disabling malignant neoplasm. Since it is a rare and heterogeneous disease, the assessment of prognostic factors remains limited. METHODS: Primary spinal glioblastomas were identified from The French Brain Tumor Database and the Club de Neuro-Oncologie of the Société Française de Neurochirurgie retrospectively...
January 23, 2023: Neurology
keyword
keyword
42824
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.